Alveera Singh believes that with the rapid increase in infections in Sub-Saharan Africa, and the high cost and limited access to synthetically derived drugs, the continent desperately needs easily available, effective, low-cost drugs. In pursuit of this, she received her Degree of Doctor of Philosophy in Biotechnology at the Durban University of Technology, South Africa, in 2016, where her research on “Bioactive compounds from South African Plants against Mycobacterium tuberculosis”, saw her testing nine medicinal plants for their ability to kill different strains of Mycobacterium tuberculosis (MTB), including the drug resist strains. In 2017, she was employed by the Africa Health Research Institute (AHRI), in Durban, to begin her Post-doctoral degree in the Kløverpris Laboratory. Singh’s current research interest is in understanding the role of innate lymphoid cells in the gut during HIV infection. She hopes her study will help her understand the mechanism of gut break down and ultimately develop new treatment strategies to prevent AIDS.